NCT06850740View on ClinicalTrials.gov

Efficacy of Co-Spinal Ondansetron In Inguinal Herniorrhaphy

NAEnrolling by invitationINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

March 15, 2025

Primary Completion Date

June 15, 2025

Study Completion Date

August 15, 2025

Conditions
Hernia, Inguinal
Interventions
DRUG

Ondansetron 8mg

Patients will receive 8 mg of ondansetron (ZOFATRONE®, 8 mg/4 mL, EVA Pharma, Egypt)

DRUG

Normal Saline

Patients will be managed by administering 100 ml of normal saline solution as placebo

Trial Locations (1)

41511

Suez Canal University, Ismailia

All Listed Sponsors
lead

Suez Canal University

OTHER